Month: January 2021

Moderna (NASDAQ:MRNA) is reaping the rewards of its successful Covid-19 vaccine, pushing MRNA stock higher and higher. It is now winning more contracts to deliver its vaccine and analysts are taking note. Source: Ascannio / Shutterstock.com And the stock has been climbing. Especially since the FDA approved its Covid-19 vaccine on Dec. 18 for emergency
0 Comments
Editor’s note: This column is part of our Best Stocks for 2021 contest. The Readers’ Choice pick for the contest is Nio (NYSE:NIO). Source: by InvestorPlace Overall, 2020 has provided quite a ride for everyone. And as we look back at the past year, some of the best stocks on Wall Street emerged from the rubble of
0 Comments
The feasibility of combinations in options trading allows profitable opportunities in varying scenarios. Be it the underlying stock prices going up, going down, or remaining stable, suitably selected option combinations offer apt profit potential.  This article goes over “strip options”, one of the market neutral trading strategies with profit potential on either side of the
0 Comments
The market’s fixation with drug manufacturers involved in treating or preventing the novel coronavirus is creating opportunities for value investors. Pfizer (NYSE:PFE), through its partnership with BioNTech SE (NASDAQ:BNTX), drew in investor interest. Between November and December, PFE stock traded no lower than $34 and topped around $43. Source: Manuel Esteban / Shutterstock.com Pfizer separated
0 Comments
In today’s near-zero interest rate environment, it’s been tough for investors looking for yield. There are many high-yielding dividend stocks to buy, but with markets at all-time highs, many of them have gotten stretched when it comes to valuation. With concerns 2020’s overvalued stock market will head lower in 2021, it may not be best
0 Comments